LILLY ENDOWMENT INC - 06 May 2026 Form 4 Insider Report for ELI LILLY & Co (LLY)

Reporting relationship: Former 10% Shareholder
Issuer ticker: LLY
Reported as of: 06 May 2026
Net transaction value: -$15,754,537
SEC form: 4
Accepted by SEC: 07 May 2026, 16:00:10 UTC
Prior SEC filing: 08 Jan 2026
Source filing: View source filing
Reporting owner signature: /s/ Diane M. Stenson, Vice President and Treasurer, on behalf of Lilly Endowment Inc.

Key filing fact

LILLY ENDOWMENT INC filed Form 4 for ELI LILLY & Co (LLY) on 07 May 2026.

Key facts

This page summarizes LILLY ENDOWMENT INC's Form 4 filing for ELI LILLY & Co (LLY).
2 reported transactions and 0 derivative rows are listed below.
Accepted by SEC: 07 May 2026, 16:00.

Change

Previous filing in this sequence was filed on 08 Jan 2026.
Current net transaction value: -$15,754,537.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0000316011 Primary reporting owner

LILLY ENDOWMENT INC

Relationship: Former 10% Shareholder
Address: 2801 NORTH MERIDIAN STREET, INDIANAPOLIS
Signature: /s/ Diane M. Stenson, Vice President and Treasurer, on behalf of Lilly Endowment Inc.
Signature date: 07 May 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

LLY transaction

Common Stock

Sale

Transaction value: $13,554,964
Shares: -13,620
Change %: -0.01%
Price: $995.22
Shares after: 91,883,358
Date: 06 May 2026
Ownership: Direct
Footnotes: F1

LLY transaction

Common Stock

Sale

Transaction value: $2,199,572
Shares: -2,208
Change %: -0%
Price: $996.18
Shares after: 91,881,150
Date: 06 May 2026
Ownership: Direct
Footnotes: F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Section 16 status

LILLY ENDOWMENT INC is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may still apply in specific circumstances.

Explanation of responses 2 footnotes

Footnote F1

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $995.00 to $995.9963, inclusive. The reporting person undertakes to provide to Eli Lilly & Company, any security holder of Eli Lilly & Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (1) and (2) to this Form 4.

Footnote F2

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $996.00 to $996.46, inclusive.